News Conference News TCT 2014 TCT Course Director Outlines Current TAVR Controversies September 14, 2014
News Conference News TCT 2014 Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients September 14, 2014
News Conference News TCT 2014 PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients September 14, 2014
News Conference News TCT 2014 Lively Debate on Use of TAVR for Lower-Risk Patients September 14, 2014
News Conference News TCT 2014 PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients Yael L. Maxwell September 13, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Conference News EuroPCR 2014 New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke L.A. McKeown May 23, 2014
News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News AHA 2013 Registry Study Summarizes Initial US Experience with First Approved TAVR Device Jason Kahn November 16, 2013
News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
News Conference News TCT 2013 Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease October 29, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013
News Conference News EuroPCR 2013 Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices Jason Kahn May 22, 2013
News Conference News ACC 2013 ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting L.A. McKeown March 14, 2013
News Conference News ACC 2013 PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished Yael L. Maxwell March 11, 2013
News Conference News ACC 2013 PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device L.A. McKeown March 09, 2013